Cardiac Dimensions
Medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation.
Launch date
Employees
Market cap
-
Enterprise valuation
€127—191m (Dealroom.co estimates Jan 2023.)
Kirkland Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$12.0m | Series B | ||
$15.0m | Series C | ||
$35.5m | Series D | ||
N/A | $6.4m | Early VC | |
N/A | $5.8m | Debt | |
N/A | - | ||
$20.0m | Seed | ||
$15.2m | Debt | ||
N/A | N/A | Early VC | |
$39.0m | Series B | ||
$17.5m Valuation: $195m | Series C | ||
* | $35.0m | Series D | |
Total Funding | €164m |
Recent News about Cardiac Dimensions
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.